07.03.2025

(DVCA) Notification on Corporate Action "Cash Dividend" - Astellas Pharma Inc ORD SHS ADR (depositary receipts ISIN US04623U1025)

Corporate Action Information
Corporate Action Reference 1015242
Corporate Action Type Code DVCA
Corporate Action Type Cash Dividend
Mandatory indicator MAND Mandatory
Value date Unknown

Security Details
Corporate Action Security Reference Issuer Security Name Category NSD Code ISIN Underlying Security Issuer Underlying Security Type Ratio ( Number of DR/ Number of Underlying Securities)
1015242D249 BNY Mellon Astellas Pharma Inc ORD SHS ADR American depository receipt US04623U1025 US04623U1025 Astellas Pharma Inc. shares ordinary 1 : 1

Corporate Action Details
Announcement Date 06 march 2025
Record Date 31 march 2025
Ex-Dividend or Distribution Date/Time 31 march 2025
Dividend Type Regular

National Settlement Depository (NSD) notifies that the information regarding Cash Dividend has been received from International Settlement and Clearing Organization.
Detailed information regarding this corporate action event will be provided to holders who have balances of these securities on their safekeeping accounts with NSD.

If you have any questions related to this communication, please contact your account managers at NSD by telephone: +7 495 956-27-90 or +7 495 956-27-91.

Print page